Deeper Dive: Understanding P3 Health Partners Inc (PIII) Through its Various Ratios

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

The price of P3 Health Partners Inc (NASDAQ: PIII) closed at $0.73 in the last session, down -1.90% from day before closing price of $0.75. In other words, the price has decreased by -$1.90 from its previous closing price. On the day, 0.53 million shares were traded. PIII stock price reached its highest trading level at $0.79 during the session, while it also had its lowest trading level at $0.6669.


We take a closer look at PIII’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 0.55. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.89.

On September 01, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $5.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 13 ’23 when Chicago Pacific Founders UGP I bought 90,000 shares for $2.65 per share. The transaction valued at 238,221 led to the insider holds 50,025,442 shares of the business.

Chicago Pacific Founders UGP I bought 90,000 shares of PIII for $236,520 on Sep 12 ’23. The 10% Owner now owns 49,935,442 shares after completing the transaction at $2.63 per share. On Sep 11 ’23, another insider, Chicago Pacific Founders UGP I, who serves as the 10% Owner of the company, bought 90,000 shares for $2.52 each. As a result, the insider paid 227,142 and bolstered with 50,115,442 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PIII now has a Market Capitalization of 376493760 and an Enterprise Value of 433135040. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.06 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 0.32 whereas that against EBITDA is -5.679.

Stock Price History:

The Beta on a monthly basis for PIII is 1.35, which has changed by -0.6770563 over the last 52 weeks, in comparison to a change of 0.25590587 over the same period for the S&P500. Over the past 52 weeks, PIII has reached a high of $5.56, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -7.54%, while the 200-Day Moving Average is calculated to be -44.39%.

Shares Statistics:

According to the various share statistics, PIII traded on average about 399.75K shares per day over the past 3-months and 431260 shares per day over the past 10 days. A total of 116.59M shares are outstanding, with a floating share count of 49.45M. Insiders hold about 58.59% of the company’s shares, while institutions hold 18.40% stake in the company. Shares short for PIII as of 1713139200 were 2259723 with a Short Ratio of 5.65, compared to 1710460800 on 2049570. Therefore, it implies a Short% of Shares Outstanding of 2259723 and a Short% of Float of 5.7800002.

Earnings Estimates

The current rating of P3 Health Partners Inc (PIII) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.15, while EPS last year was -$0.22. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.07 and low estimates of -$0.11.

Analysts are recommending an EPS of between -$0.14 and -$0.36 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.21, with 2.0 analysts recommending between -$0.15 and -$0.28.

Revenue Estimates

According to 5 analysts, the current quarter’s revenue is expected to be $388.49M. It ranges from a high estimate of $370.6M to a low estimate of $333.74M. As of the current estimate, P3 Health Partners Inc’s year-ago sales were $302.08MFor the next quarter, 5 analysts are estimating revenue of $367.54M. There is a high estimate of $377.8M for the next quarter, whereas the lowest estimate is $360M.

A total of 5 analysts have provided revenue estimates for PIII’s current fiscal year. The highest revenue estimate was $1.56B, while the lowest revenue estimate was $1.45B, resulting in an average revenue estimate of $1.49B. In the same quarter a year ago, actual revenue was $1.27BBased on 4 analysts’ estimates, the company’s revenue will be $1.73B in the next fiscal year. The high estimate is $1.83B and the low estimate is $1.59B.

Most Popular

[the_ad id="945"]